Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Closes $10M Financing Agreement

NEW YORK (GenomeWeb) – Canadian diagnostic developer GeneNews said today that it has closed a previously announced $10 million financing deal with private equity firm Milost Global.

In June, GeneNews announced that it had signed an equity and debt subscription agreement with Milost. According to GeneNews, the deal includes up to $4 million in its common shares to be drawn down at its option — in maximum installments of $1 million — and up to $6 million in unsecured convertible notes in tranches not to exceed $3 million.

GeneNews said today that it will make an initial draw down of $500,000, to be completed immediately. The common share purchase will be priced at a 50 percent premium to the 20-day volume weighted average price of GeneNews' common shares on the Toronto Stock Exchange on the date of the draw-down notice, the firm added.

GeneNews also said that this first tranche is designed to "to fuel the company's momentum while minimizing dilution," and will be followed up with additional tranches as needed.

In August, GeneNews reported cash and cash equivalents totaling $61,154 at the end of the second quarter.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.